Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
AMGN
Amgen
$305.69
Chart
$288.47 (+5.97%)
$277.29 (+10.24%)
$317.82 (-3.82%)
$332.51 (-8.07%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
AMGN
Amgen
Current Price
$305.69
Sell
Login to view Amgen (AMGN) recommendation from the last 90 days from financial news and social media.
Chart
$288.47 (+5.97%)
$277.29 (+10.24%)
$317.82 (-3.82%)
$332.51 (-8.07%)
AMGN Latest Analysis
Notable Tuesday Option Activity: AMGN DAL FDS. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Amgen Inc (Symbol: AMGN) where a total volume of 13129 contracts has been traded thus far today a contract volume which is representative of approximately 1.3
Today
What Analysts Are Saying About Amgen Stock. Analysts'. ratings for Amgen (NASDAQ:) over the last quarter vary from ish to bearish as provided by 8 analysts.In the table below you'.ll find a summary of their recent ratings revealing the shifting sentiments over the past 30 days and comparing them to the previous months.0350000100011000000002300Analysts have recently evaluated Amgen and provided 12-month price targets. The average target is $311.25 accompanied by a high estimate of $328.00
Mon Jul 21, 2025
This Is What Whales Are Betting On Amgen. Investors with a lot of money to spend have taken a ish stance on ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with AMGN it often means somebody knows something is about to happen.So how do we know what these investors just did? Today Ben
Mon Jul 21, 2025
What Does the Market Think About Amgen?. ) short percent of float has risen 11.34% since its last report. The company recently reported that it has Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price ...
Fri Jul 11, 2025
This House of Representative Just Bought Up To $30K In Amgen Stock. A report on July 9 2025 shows that Representative Cliff Bentz from Oregon purchase stock in Amgen (NASDAQ:) valued between $2002 and $30000. According to the July filing the transaction occurred on June 6 2025.At the time of writing Amgen shares are trading down 0.11% at $296.19.Over the previous three years Cliff Bentz conducted 5 trades totaling more than $254 thousand. The largest of these were in Amgen and Procter &. Gamb
Thu Jul 10, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
AMGN Stock trends
AMGN Stock performance
AMGN Stock analysis
AMGN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings